Yu Fa-Xing, Zhao Bin, Guan Kun-Liang
Children's Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China.
Life Sciences Institute and Innovation Center for Cell Signaling Network, Zhejiang University, Hangzhou, Zhejiang 310058, China.
Cell. 2015 Nov 5;163(4):811-28. doi: 10.1016/j.cell.2015.10.044.
Two decades of studies in multiple model organisms have established the Hippo pathway as a key regulator of organ size and tissue homeostasis. By inhibiting YAP and TAZ transcription co-activators, the Hippo pathway regulates cell proliferation, apoptosis, and stemness in response to a wide range of extracellular and intracellular signals, including cell-cell contact, cell polarity, mechanical cues, ligands of G-protein-coupled receptors, and cellular energy status. Dysregulation of the Hippo pathway exerts a significant impact on cancer development. Further investigation of the functions and regulatory mechanisms of this pathway will help uncovering the mystery of organ size control and identify new targets for cancer treatment.
二十年来在多种模式生物中的研究已确立了Hippo信号通路是器官大小和组织稳态的关键调节因子。通过抑制YAP和TAZ转录共激活因子,Hippo信号通路响应多种细胞外和细胞内信号(包括细胞间接触、细胞极性、机械信号、G蛋白偶联受体的配体以及细胞能量状态)来调节细胞增殖、凋亡和干性。Hippo信号通路的失调对癌症发展产生重大影响。对该信号通路的功能和调控机制进行进一步研究将有助于揭开器官大小控制的奥秘,并确定癌症治疗的新靶点。